Therapeutic uses of copper-chelating agents
- PMID: 6907089
Therapeutic uses of copper-chelating agents
Abstract
Equilibrium analysis of a model system for the in vivo reactions between penicillamine and copper (I), the penicillamine--glutathione--Cu(I) system, indicates that in a certain concentration range the therapeutic use of penicillamine will not disturb the normal Cu(I) metabolism. The equilibrium data required for this analysis were obtained by e.m.f. titrations on the Cu(I)-glutathione (H3A) and on the Cu(I)-penicillamine (H2A) systems at 25 degree C, in 0.5 M NaClO4 medium, using glass and copper amalgam electrodes; the data were analysed first by various graphical methods and then by a general least-squares computer program. The results show that mononuclear Cu(I) species, Cu(HA)2, from in both systems; in addition, the polynuclear Cu5A4(3-) species forms in the penicillamine system and the mononuclear CuHA- species might form in the glutathione system. The results are discussed in relation to the therapeutic use of penicillamine.
Similar articles
-
Copper(I) complexes of penicillamine and glutathione.J Inorg Biochem. 1979 Jul;10(4):341-55. doi: 10.1016/s0162-0134(00)80200-7. J Inorg Biochem. 1979. PMID: 38301
-
Penicillamine metal chelates and their possible importance in rheumatoid arthritis--a brief review.Clin Invest Med. 1984;7(1):41-4. Clin Invest Med. 1984. PMID: 6723123
-
[Pharmacology and mechanism of action of D-penicillamine in rheumatoid polyarthritis].Rev Rhum Mal Osteoartic. 1983 May;50(6):457-63. Rev Rhum Mal Osteoartic. 1983. PMID: 6351235 Review. French.
-
[Copper metabolism in rheumatoid arthritis and influence of D-penicillamine treatment].Rev Rhum Mal Osteoartic. 1973 Jul-Sep;40(7):485-9. Rev Rhum Mal Osteoartic. 1973. PMID: 4756424 French. No abstract available.
-
[Penicillamine in the treatment of scleroderma. Lathyrogenic drugs].Przegl Dermatol. 1971 May-Jun;58(3):355-9. Przegl Dermatol. 1971. PMID: 4944035 Review. Polish. No abstract available.